Regulus Therapeutics Inc (NASDAQ:RGLS)

0.1999
Delayed Data
As of Jan 24
 -0.0241 / -10.76%
Today’s Change
0.19
Today|||52-Week Range
2.32
-36.54%
Year-to-Date

Today’s Trading

Previous close0.22
Today’s open0.22
Day’s range0.19 - 0.22
Volume256,264
Average volume (3 months)1,910,937
Market cap$19.5M
Data as of 3:58pm ET, 01/24/2022

Growth & Valuation

Earnings growth (last year)+58.25%
Earnings growth (this year)+25.56%
Earnings growth (next 5 years)--
Revenue growth (last year)+46.46%
P/E ratioNM
Price/Sales4.72
Price/Book0.58

Competitors

 Today’s
change
Today’s
% change
IMRNImmuron Ltd+0.11+3.12%
----
KTRAKintara Therapeutics...-0.02-6.30%
----
Data as of 4:03pm ET, 01/24/2022

Financials

Next reporting dateMarch 9, 2022
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$10.0M
Annual profit (last year)-$15.7M
Net profit margin-157.21%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
No executives to display
Corporate headquarters
San Diego, California

Forecasts